INDUCTION OF HEME OXYGENASE IN TOXIC RENAL INJURY - A PROTECTIVE ROLE IN CISPLATIN NEPHROTOXICITY IN THE RAT

被引:230
作者
AGARWAL, A
BALLA, J
ALAM, J
CROATT, AJ
NATH, KA
机构
[1] UNIV MINNESOTA, SCH MED, DEPT MED, DIV RENAL, MINNEAPOLIS, MN USA
[2] ALTON OCHSNER MED FDN & OCHSNER CLIN, DEPT MOLEC GENET, NEW ORLEANS, LA USA
关键词
D O I
10.1038/ki.1995.414
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cellular content of heme is regulated by heme oxygenase, the rate limiting enzyme in the degradation of heme. Induction of heme oxygenase is a protective response in an in vivo model of heme protein mediated renal injury, the glycerol model of acute renal failure. In addition to heme, heme oxygenase is induced by diverse forms of oxidative stress, the functional significance of which is currently unknown. We examined whether heme oxygenase is induced, and the functional significance of such induction, in two in vivo models of oxidant-induced toxic nephropathy, namely, cisplatin and gentamicin nephropathies; nephrotoxicity in these models is not dependent on the delivery of a burden of heme proteins to the kidney as occurs in the glycerol model. We demonstrate induction of heme oxygenase mRNA and protein in the kidney as early as 6 and 12 hours after a single dose of cisplatin (6 mg/kg i.v.). Pretreatment with tin protoporphyrin, a competitive inhibitor of heme oxygenase, led to higher serum creatinine values on days 3 through 5 and lower inulin clearances on day 5; tin protoporphyrin also exacerbated renal injury in this model. Renal hemodynamics studied at day 2 after cisplatin demonstrate reduced renal blood how rates, increased renal vascular resistance and increased fractional excretion of sodium in rats treated with tin protoporphyrin. Tin protoporphyrin alone had no significant effect on serum creatinine and renal hemodynamics in rats with intact, disease-free kidneys. We confirmed that tin protoporphyrin prevented the increase in heme oxygenase activity induced by cisplatin. Induction of heme oxygenase by cisplatin was associated with increased kidney heme content and ferritin content. Induction of heme oxygenase, as measured by mRNA and protein content, also occurred in gentamicin nephropathy, though less than that observed in cisplatin nephropathy. Inhibition of heme oxygenase did not influence sequential serum creatinine determinations in gentamicin nephropathy, thus indicating heterogeneity in the functional significance of induction of heme oxygenase in oxidative stress. We conclude that the induction of heme oxygenase is a protective response in toxic nephropathy, specifically, in cisplatin nephropathy. Ferritin content is also increased by cisplatin, and by sequestering iron, may subserve a beneficial role in this model, Endogenous heme, released from heme proteins, is potentially toxic and may contribute to cisplatin nephrotoxicity.
引用
收藏
页码:1298 / 1307
页数:10
相关论文
共 50 条
[1]   THE PHYSIOLOGICAL SIGNIFICANCE OF HEME OXYGENASE [J].
ABRAHAM, NG ;
LIN, JHC ;
SCHWARTZMAN, ML ;
LEVERE, RD ;
SHIBAHARA, S .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1988, 20 (06) :543-&
[2]  
Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
[3]  
ANTH KA, 1994, J LAB CLIN MED, V123, P461
[4]   ROLE OF GLUTATHIONE FOR CISPLATIN NEPHROTOXICITY IN YOUNG AND ADULT-RATS [J].
APPENROTH, D ;
WINNEFELD, K .
RENAL FAILURE, 1993, 15 (02) :135-139
[5]  
APPLEGATE LA, 1991, CANCER RES, V51, P974
[6]   NITRIC-OXIDE IN THE KIDNEY - SYNTHESIS, LOCALIZATION, AND FUNCTION [J].
BACHMANN, S ;
MUNDEL, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (01) :112-129
[7]  
BALLA G, 1992, J BIOL CHEM, V267, P18148
[8]   SIMULTANEOUS DETERMINATION OF HEMES-A, HEMES-B, AND HEMES-C FROM PYRIDINE HEMOCHROME SPECTRA [J].
BERRY, EA ;
TRUMPOWER, BL .
ANALYTICAL BIOCHEMISTRY, 1987, 161 (01) :1-15
[9]   MITOCHONDRIAL INJURY - AN EARLY EVENT IN CISPLATIN TOXICITY TO RENAL PROXIMAL TUBULES [J].
BRADY, HR ;
KONE, BC ;
STROMSKI, ME ;
ZEIDEL, ML ;
GIEBISCH, G ;
GULLANS, SR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (05) :F1181-F1187
[10]  
BRADY HR, 1993, J PHARMACOL EXP THER, V265, P1421